全文获取类型
收费全文 | 14470篇 |
免费 | 1101篇 |
国内免费 | 823篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 654篇 |
妇产科学 | 33篇 |
基础医学 | 2429篇 |
口腔科学 | 451篇 |
临床医学 | 1632篇 |
内科学 | 2708篇 |
皮肤病学 | 113篇 |
神经病学 | 613篇 |
特种医学 | 730篇 |
外国民族医学 | 3篇 |
外科学 | 1859篇 |
综合类 | 2580篇 |
现状与发展 | 1篇 |
预防医学 | 254篇 |
眼科学 | 73篇 |
药学 | 677篇 |
5篇 | |
中国医学 | 443篇 |
肿瘤学 | 1120篇 |
出版年
2023年 | 126篇 |
2022年 | 186篇 |
2021年 | 267篇 |
2020年 | 292篇 |
2019年 | 300篇 |
2018年 | 335篇 |
2017年 | 337篇 |
2016年 | 376篇 |
2015年 | 423篇 |
2014年 | 832篇 |
2013年 | 998篇 |
2012年 | 684篇 |
2011年 | 887篇 |
2010年 | 796篇 |
2009年 | 770篇 |
2008年 | 772篇 |
2007年 | 853篇 |
2006年 | 854篇 |
2005年 | 874篇 |
2004年 | 718篇 |
2003年 | 589篇 |
2002年 | 472篇 |
2001年 | 365篇 |
2000年 | 329篇 |
1999年 | 302篇 |
1998年 | 219篇 |
1997年 | 259篇 |
1996年 | 233篇 |
1995年 | 229篇 |
1994年 | 245篇 |
1993年 | 144篇 |
1992年 | 155篇 |
1991年 | 149篇 |
1990年 | 107篇 |
1989年 | 88篇 |
1988年 | 97篇 |
1987年 | 83篇 |
1986年 | 70篇 |
1985年 | 104篇 |
1984年 | 76篇 |
1983年 | 56篇 |
1982年 | 50篇 |
1981年 | 46篇 |
1980年 | 51篇 |
1979年 | 52篇 |
1978年 | 49篇 |
1977年 | 40篇 |
1976年 | 26篇 |
1975年 | 14篇 |
1973年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 521 毫秒
1.
Forensic pathologists often encounter autopsies that require an assessment of antemortem general conditions (e.g., infection, metabolic disorders). To establish evaluation clues for such cases, we quantitatively examined macrophages and the general pathology of bone marrow in samples from 180 forensic autopsy cases of decedents with various conditions. Hematoxylin-eosin staining, Berlin blue staining, and immunostainings for CD163, CD138, and CD61 were performed. We determined the numbers per field (density) of total macrophages, swollen macrophages, macrophages with hemophagocytosis, and hemosiderin-laden macrophages. Each density was standardized by identifying its ratio to the total number of macrophages. The decedents' background data (cause of death, other pathological findings, postmortem interval, antemortem symptoms, and presence of resuscitation) were extracted. No correlations were found between the postmortem interval and the other decedent data, indicating that these data are not affected by postmortem changes. In the group in which inflammatory disease was the cause of death, there were significant elevations in the ratio of the swollen macrophage density to total macrophages. Significantly higher ratios of the density of swollen and hemophagocytic macrophages were observed in the group in which conditions with a prolonged agonal period were the cause of death. The group with a return of spontaneous circulation to resuscitation showed a significantly higher ratio of macrophage density with hemophagocytosis. This study provides the first statistical analysis focused on bone marrow histopathology in forensic autopsies. The results will be useful for elucidating causes of death and agonal-period conditions. 相似文献
2.
3.
4.
2型糖尿病及骨质疏松已成为我国最主要的慢性代谢性疾病。2型糖尿病常伴有血脂紊乱,常表现为低密度脂蛋白升高,而越来越多的研究表明血脂通过不同的方式影响骨代谢,其机制可能是通过抑制骨髓间充质干细胞成骨分化,通过RANK/RNAKL/OPG信号通路及炎症反应调节破骨细胞等方式调节骨代谢。 相似文献
5.
《Journal of Medical Imaging and Radiation Sciences》2015,46(4):442-449
The purpose of this literature review is to investigate clinical treatment methods of total body irradiation within the context of a clinical department adopting a paediatric cohort with no existing technique. An extensive review of the literature was conducted using PubMed, Science Direct, Google Scholar, and Clinicians Knowledge Network. Articles were limited to nonhelical tomotherapy, nonparticle therapies, and those using hyperfractionated regimes. Total marrow irradiation was excluded because of national treatment and trial limitations. Of the numerous patient positioning methods present within the literature, the most comfortable and reproducible positioning methods for total body irradiation include both supine and the supine and/or prone combination. These positions increased stability and patient comfort during treatment, while also facilitating computed tomography data acquisition at the simulation stage. Ideally, dose calculations should be performed using a three-dimensional treatment planning system and quality assurance procedures that include in vivo dosimetry measurements. The available literature also suggests inhomogeneity correction factors and intensity modulation are superior to conventional open field techniques and should be implemented within developing protocols. Dynamic machine dose modulation is suggested to reduce department impact, removing the need for tissue compensators and accessory shielding devices, while providing significant improvements to treatment time and dose accuracy. Further long-term survival and intensity modulation studies are warranted, including direct comparisons of both dose modulation and treatment efficiency. 相似文献
6.
《Clinical Lymphoma, Myeloma & Leukemia》2020,20(7):415-421
Myelofibrosis (MF) is a BCR-ABL1− myeloproliferative neoplasm that arises from hematopoietic stem and progenitor cells frequently harboring a somatic driver mutation in 1 of 3 genes: JAK2, CALR, or MPL. The pathologic features of this hematologic malignancy include myeloproliferation, diffuse bone marrow fibrosis, and overactivation of the JAK-STAT pathway, resulting in enhanced inflammatory cytokine release. The common clinical manifestations of MF include systemic symptoms, abnormal peripheral blood count levels, and splenomegaly. However, it has become increasingly appreciated that significant clinical heterogeneity exists among patients with MF. Two distinct MF clinical phenotypes include the myeloproliferative and myelodepletive phenotype, with peripheral blood counts being the main discerning feature. Patients with the myeloproliferative phenotype will present with elevated peripheral blood counts and often experience significant constitutional symptoms and progressive splenomegaly. In contrast, patients with the myelodepletive phenotype will have low peripheral blood counts and will frequently require transfusion support. Current frontline therapies for MF, include ruxolitinib and fedratinib, which can exacerbate cytopenias and thereby pose an impediment to effective treatment of the myelodepletive patient. The present review discusses the clinical and prognostic implications of the myelodepletive phenotype and the therapeutic options and limitations for this subset of patients, representing an unmet clinical need. 相似文献
7.
8.
C. Banella M. Ginevrino G. Catalano E. Fabiani G. Falconi M. Divona P. Curzi P. Panetta M.T. Voso N.I. Noguera 《Hematology/oncology and stem cell therapy》2021,14(2):163-168
FGFR–TACC, found in different tumor types, is characterized by the fusion of a member of fibroblast grown factor receptor (FGFR) tyrosine kinase (TK) family to a member of the transforming acidic coiled-coil (TACC) proteins. Because chromosome numerical alterations, hallmarks of FGFR–TACC fusions are present in many hematological disorders and there are no data on the prevalence, we studied a series of patients with acute myeloid leukemia and myelodysplastic syndrome who presented numerical alterations using cytogenetic traditional analysis. None of the analyzed samples showed FGFR3–TACC3 gene fusion, so screening for this mutation at diagnosis is not recommended. 相似文献
9.
目的:研究非霍奇金淋巴瘤(non-Hodgkin' s lymphoma,NHL)骨髓侵犯患者骨髓病灶中间隙连接蛋白(connexin,Cx)43表达情况。 方法:选取我院确诊的非霍奇金淋巴瘤骨髓侵犯患者26例,骨髓组织中查见呈灶性分布且已通过免疫组化证实为反应性淋巴细胞增生的患者9例,正常骨髓组织10例行免疫组化染色,根据阳性率及阳性程度评分后进行统计学分析。 结果:Cx43在NHL样本中的阳性率(30.8%)低于在反应性淋巴细胞增生样本(88.9%)及正常样本(100%)中的阳性率,差异有统计学意义(P<0.05)。而反应性淋巴细胞增生样本和正常样本间Cx43阳性率无统计学意义(P>0.05),但反应性淋巴细胞增生样本的阳性积分明显低于正常样本(P<0.05)。结论:非霍奇金淋巴瘤骨髓侵犯时病灶处Cx43表达情况显著低于反应性淋巴细胞增生及正常骨髓组织。 相似文献
10.
目的:自体骨髓移植联合MHC单倍体相合淋巴细胞治疗急性髓性白血病的治疗效果和安全性。方法:以40例急性髓性白血病患者作为研究对象,随机分为两组各20例,研究组患者使用自体骨髓移植联合MHC单倍体相合淋巴细胞进行治疗,对照组单用自体骨髓移植进行治疗。结果:两组患者的造血系统都得到重建,重建时间以及并发症的发生均没有显著差异。而研究组患者复发率显著降低,且复发时间明显地长于对照组患者。研究组患者3年累积无病生存率明显地高于对照组患者,且差异具有统计学意义。结论:自体骨髓移植联合MHC单倍体相合淋巴细胞治疗能够有效控制急性髓性白血病病情,降低其复发,延长患者生存期。 相似文献